Powell’s speech, Nvidia’s chips, Meta deal - what’s moving markets
BRENTWOOD, Tenn. -On Monday, Surgery Partners, Inc. (NASDAQ:SGRY) reported fourth quarter results that exceeded analyst expectations.
The company’s shares were up 3.78% in premarket trading after the release.
The short-stay surgical facility operator posted adjusted earnings per share of $0.44, beating the analyst estimate of $0.39. Revenue came in at $864.4 million, surpassing expectations of $827.9 million and representing a 17.5% increase YoY.
For the full year 2024, Surgery Partners saw revenue climb 13.5% to $3.1 billion. Same-facility revenue grew 8% YoY, driven by a 3.9% increase in cases and a 4% rise in revenue per case.
Looking ahead, the company provided an upbeat outlook for 2025. It expects full-year revenue between $3.30 billion and $3.45 billion, the midpoint of which is slightly above the $3.38 billion analyst consensus.
"We are pleased to report another year of mid-teens growth, while continuing to expand margin," said CEO Eric Evans. "Our 2024 results are a continuation of the Company’s consistent and predictable organic growth."
CFO Dave Doherty noted the company’s strong liquidity position of over $770 million, which he said enhances their "confidence and ability to continue to fund accretive M&A without the need to access the capital markets."
Surgery Partners continues to benefit from the trend toward outpatient procedures and its strategic expansion efforts.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.